Medically-Based Enterprise Risk Management
A Retrospective on Firsts
When Dr. Ronald E. Gots started National Medical Advisory Service in 1975, he had no idea what a multi-faceted and exciting journey he had embarked upon – after all he was a young naïve, newly minted physician and scientist. But varied and intellectually challenging it has been. The common theme of all of our client services was, and remains, providing the best of medical and scientific consulting expertise and services. That theme, for The NMAS Group and its affiliated companies, has taken us down a winding path that includes:
- Direct patient care,
- Litigation support for plaintiffs and defendants,
- Risk management for major corporations and insurers,
- Drug labeling for the Food and Drug Administration,
- Environmental risk communication for fortune 500 companies,
- Building science investigation and remediation oversight in indoor spaces ranging from 3000 home housing communities to luxury hotels,
- Automated management of medical and scientific information in 1000 claimant mass tort claims, to, recently,
- A major epidemiological study of the National Security Administration (NSA) and it's many buildings.
Dr. Gots and his colleagues were the first to develop:
- A national coordinated program for an expensive and common tort—obstetrical malpractice (the so-called "bad baby cases") which was prepared for the St. Paul Insurance Company in 1980.
- An automated personal injury medical claims analysis system, which is commonly used today.
- A common package insert for classes of pharmaceutical agents.
- A team of nurses who, using an automated system, converted incomprehensible medical records to an easily-managed and read computerized record. This system, actively employed today, is an invaluable asset for medical record management in complex personal injury litigation.
- A proprietary system for automating causation analysis in mass tort litigation. The NMAS Group T2S2 system is available for clients today.
Whether your issue involves a product posing a potential toxicological hazard, a pharmaceutical agent accused of causing harm, a medical device of dubious value for which reimbursement is demanded of you, a building with water incursions or a single claimant or multi-litigant lawsuit claiming current injuries or future risk, or the need for epidemiological or toxicological investigation, The NMAS Group is available to support your challenge and anxious to do so.